MCID: MNN006
MIFTS: 37

Meninges Hemangiopericytoma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Meninges Hemangiopericytoma

MalaCards integrated aliases for Meninges Hemangiopericytoma:

Name: Meninges Hemangiopericytoma 12 15
Hemangiopericytoma of Meninges 12 73
Meningeal Hemangiopericytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4957
NCIt 50 C4660
SNOMED-CT 68 277522009
UMLS 73 C0349622

Summaries for Meninges Hemangiopericytoma

MalaCards based summary : Meninges Hemangiopericytoma, also known as hemangiopericytoma of meninges, is related to hemangiopericytoma, malignant and mesenchymal chondrosarcoma. An important gene associated with Meninges Hemangiopericytoma is STAT6 (Signal Transducer And Activator Of Transcription 6), and among its related pathways/superpathways are Pathways in cancer and Immune response Function of MEF2 in T lymphocytes. The drugs Doxorubicin and Mechlorethamine have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and liver, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Meninges Hemangiopericytoma

Diseases related to Meninges Hemangiopericytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 17)
# Related Disease Score Top Affiliating Genes
1 hemangiopericytoma, malignant 28.7 IGF2 STAT6 VIM
2 mesenchymal chondrosarcoma 28.0 HEY1 NCOA2 VIM
3 meningitis 10.6
4 hypoglycemia 10.1
5 hepatitis 10.0
6 periosteal chondrosarcoma 9.8 HEY1 NCOA2
7 retinoblastoma 9.8
8 chondrosarcoma 9.8
9 pancreatitis 9.8
10 fibrous meningioma 9.8
11 meningothelial meningioma 9.8
12 rhabdoid cancer 9.5 IGF2 VIM
13 atypical teratoid rhabdoid tumor 9.5 IGF2 VIM
14 leiomyosarcoma 9.4 IGF2 VIM
15 leiomyoma 9.3 IGF2 VIM
16 gastrointestinal stromal tumor 9.2 IGF2 VIM
17 meningioma, familial 9.0 IGF2 VIM

Graphical network of the top 20 diseases related to Meninges Hemangiopericytoma:



Diseases related to Meninges Hemangiopericytoma

Symptoms & Phenotypes for Meninges Hemangiopericytoma

GenomeRNAi Phenotypes related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

26 (show all 22)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 9.6 NCOA2
2 Increased shRNA abundance (Z-score > 2) GR00366-A-105 9.6 VIM
3 Increased shRNA abundance (Z-score > 2) GR00366-A-146 9.6 VIM
4 Increased shRNA abundance (Z-score > 2) GR00366-A-176 9.6 VIM
5 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.6 VIM STAT6
6 Increased shRNA abundance (Z-score > 2) GR00366-A-189 9.6 NCOA2 STAT6 VIM
7 Increased shRNA abundance (Z-score > 2) GR00366-A-190 9.6 VIM
8 Increased shRNA abundance (Z-score > 2) GR00366-A-201 9.6 STAT6
9 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.6 VIM
10 Increased shRNA abundance (Z-score > 2) GR00366-A-30 9.6 VIM
11 Increased shRNA abundance (Z-score > 2) GR00366-A-39 9.6 STAT6
12 Increased shRNA abundance (Z-score > 2) GR00366-A-43 9.6 STAT6
13 Increased shRNA abundance (Z-score > 2) GR00366-A-54 9.6 STAT6
14 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.6 VIM
15 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.6 STAT6
16 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.6 VIM
17 Decreased shRNA abundance (Z-score < -2) GR00366-A-134 9.5 VIM
18 Decreased shRNA abundance (Z-score < -2) GR00366-A-150 9.5 NCOA2
19 Decreased shRNA abundance (Z-score < -2) GR00366-A-212 9.5 VIM NCOA2
20 Decreased shRNA abundance (Z-score < -2) GR00366-A-33 9.5 NCOA2
21 Decreased shRNA abundance (Z-score < -2) GR00366-A-59 9.5 NCOA2
22 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.5 VIM

MGI Mouse Phenotypes related to Meninges Hemangiopericytoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.55 HEY1 IGF2 NCOA2 STAT6 VIM
2 embryo MP:0005380 9.26 HEY1 IGF2 NCOA2 VIM
3 reproductive system MP:0005389 8.92 IGF2 NCOA2 STAT6 VIM

Drugs & Therapeutics for Meninges Hemangiopericytoma

Drugs for Meninges Hemangiopericytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 132)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
2
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
3
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
4
Lenograstim Approved, Investigational Phase 3,Phase 2 135968-09-1
5
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
6
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
7
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
8
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
9
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
10
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
11
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 2019 457193
12
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
13
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
14
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
15 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
16
Isophosphamide mustard Phase 3,Phase 2,Phase 1 0
17 Alkylating Agents Phase 3,Phase 2,Phase 1
18 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
19 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
20 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
21 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
22 Analgesics Phase 3,Phase 1
23 Central Nervous System Depressants Phase 3
24 Adjuvants, Anesthesia Phase 3
25 Cholinergic Agents Phase 3,Phase 2
26 Cholinesterase Inhibitors Phase 3,Phase 2
27 Narcotics Phase 3
28 Neurotransmitter Agents Phase 3,Phase 2
29 Analgesics, Opioid Phase 3
30 Anesthetics Phase 3
31 Nootropic Agents Phase 3,Phase 2
32 Anesthetics, General Phase 3
33 Anesthetics, Intravenous Phase 3
34 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
35 Peripheral Nervous System Agents Phase 3,Phase 1
36 Etoposide phosphate Phase 3,Phase 2
37 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
38 Anti-Infective Agents Phase 3,Phase 2,Phase 1
39 Liver Extracts Phase 3,Phase 1
40 Antirheumatic Agents Phase 3,Phase 2,Phase 1
41 Antimitotic Agents Phase 3,Phase 2,Phase 1
42 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
43 Cola Nutraceutical Phase 3,Phase 1
44
Dacarbazine Approved, Investigational Phase 2,Phase 1 4342-03-4 5351166
45
Temozolomide Approved, Investigational Phase 2,Phase 1 85622-93-1 5394
46
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
47
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
48
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
49
Bevacizumab Approved, Investigational Phase 2 216974-75-3
50
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062

Interventional clinical trials:

(show top 50) (show all 60)
# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
3 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
4 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
5 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
6 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
7 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
8 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
9 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
10 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
11 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
12 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
13 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed NCT00589784 Phase 2 Sunitinib
14 Imatinib Mesylate in Treating Patients With Recurrent Meningioma Completed NCT00045734 Phase 2 imatinib mesylate
15 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
16 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
17 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
18 Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed NCT00154388 Phase 2 Imatinib mesylate
19 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00348790 Phase 2 vatalanib
20 S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas Completed NCT00217620 Phase 2 sorafenib
21 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
22 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
23 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
24 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
25 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
26 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
27 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
28 Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Completed NCT00025675 Phase 2 gefitinib
29 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
30 Proton Radiation For Meningiomas and Hemangiopericytomas Recruiting NCT01117844 Phase 1, Phase 2
31 Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Recruiting NCT01532687 Phase 2 Gemcitabine Hydrochloride;Pazopanib Hydrochloride
32 Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes Recruiting NCT02815995 Phase 2 Durvalumab;Tremelimumab
33 Trial of Dasatinib in Advanced Sarcomas Active, not recruiting NCT00464620 Phase 2 Dasatinib
34 Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas Active, not recruiting NCT01125046 Phase 2
35 A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma Not yet recruiting NCT03016091 Phase 2 Pembrolizumab
36 S9624 Ifosfamide in Treating Patients With Meningeal Tumors Terminated NCT00003292 Phase 2 ifosfamide
37 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
38 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
39 Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Gluco Completed NCT01082926 Phase 1
40 Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Completed NCT00720174 Phase 1 Doxorubicin Hydrochloride
41 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
42 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
43 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914 Phase 1 temsirolimus
44 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
45 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1 bortezomib;temozolomide
46 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
47 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
48 CC-5013 in Treating Patients With Recurrent Glioma Completed NCT00036894 Phase 1 lenalidomide
49 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
50 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat

Search NIH Clinical Center for Meninges Hemangiopericytoma

Genetic Tests for Meninges Hemangiopericytoma

Anatomical Context for Meninges Hemangiopericytoma

MalaCards organs/tissues related to Meninges Hemangiopericytoma:

41
Brain, Bone, Liver, Lung, T Cells, Testes, Adrenal Gland

Publications for Meninges Hemangiopericytoma

Articles related to Meninges Hemangiopericytoma:

(show all 50)
# Title Authors Year
1
Meningeal Hemangiopericytoma in 33-Year-Old Female; a Case Report. ( 27799979 )
2016
2
NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor. ( 26883114 )
2016
3
Liver metastasis of meningeal hemangiopericytoma: a study of 5 cases. ( 27044772 )
2016
4
Gastric metastasis from malignant meningeal hemangiopericytoma. ( 27801496 )
2016
5
Intracranial meningeal hemangiopericytoma: Recurrences at the initial and distant intracranial sites and extraneural metastases to multiple organs. ( 26171177 )
2015
6
Liver metastases from meningeal hemangiopericytoma. ( 25913235 )
2015
7
Living-Donor Liver Transplantation for Hepatic Metastasis FromA Meningeal Hemangiopericytoma: A Case Report. ( 26361698 )
2015
8
Meningeal hemangiopericytoma only diagnosed at the time of late bone metastasis. ( 24934329 )
2014
9
Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion. ( 24124145 )
2013
10
Metastasis of intracranial meningeal hemangiopericytoma to thoracic spine 17A years after surgical excision: a case report. ( 23943153 )
2013
11
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. ( 23575898 )
2013
12
Optic nerve meningeal hemangiopericytoma: a clinicopathologic case report. ( 23294915 )
2013
13
The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database. ( 22867893 )
2013
14
Intracranial meningeal hemangiopericytoma metastatic to the scapula. ( 22229602 )
2012
15
Recurrent meningeal hemangiopericytoma with multiple metastasis and hypoglycemia: a case report. ( 23024657 )
2012
16
Meningeal Hemangiopericytoma with Intracranial Metastases in an HIV-Positive Male: Case Report and Review of the Literature. ( 22666206 )
2012
17
MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma. ( 22824994 )
2012
18
Intracranial meningeal hemangiopericytoma: 10A years experience of a tertiary care Institute. ( 22790838 )
2012
19
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. ( 21558077 )
2011
20
The status of MGMT protein expression is a prognostic factor for meningeal hemangiopericytoma: a clinicopathologic and immunohistochemical study of 12 cases at a single institution. ( 21667225 )
2011
21
Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: a comparison. ( 20165866 )
2010
22
Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma. ( 20622667 )
2010
23
Multiple metastatic progression of meningeal hemangiopericytoma initially diagnosed as atypical meningioma with temporal bone invasion. ( 19201308 )
2009
24
Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy. ( 18459177 )
2008
25
Meningeal hemangiopericytoma manifesting as massive intracranial hemorrhage--two case reports. ( 16498220 )
2006
26
Bone metastasis of intracranial meningeal hemangiopericytoma. ( 15990973 )
2005
27
Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. ( 15042684 )
2004
28
Meningeal hemangiopericytoma metastatic to the adrenal gland with multiple metastases to bones and lungs: a case report. ( 15143990 )
2004
29
[Multiple extracranial metastases from a meningeal hemangiopericytoma and severe hypoglycemia: a case report]. ( 15227844 )
2004
30
Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. ( 15668900 )
2004
31
Meningeal hemangiopericytoma with delayed multiple distant metastases. ( 15648288 )
2004
32
Fine needle aspiration cytology of hepatic metastasis from a meningeal hemangiopericytoma. A case report. ( 12685202 )
2003
33
Fetal meningeal hemangiopericytoma. Case report. ( 12450048 )
2002
34
Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. ( 11322435 )
2001
35
Four cases of meningeal hemangiopericytoma treated with surgery and radiotherapy. ( 11773263 )
2001
36
Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma. ( 11266526 )
2001
37
Tc-99m MDP and Tl-201 scintigraphy in a case of metastatic meningeal hemangiopericytoma. ( 11711721 )
2001
38
[Contribution of immunohistochemistry and electron microscopy for the diagnosis of meningeal hemangiopericytomas. 15 case reports]. ( 11084416 )
2000
39
Meningeal hemangiopericytoma in childhood. ( 11003400 )
2000
40
Pancreatic head mass from metastatic meningeal hemangiopericytoma. ( 18521297 )
2000
41
Hepatic and pulmonary metastases from a meningeal hemangiopericytoma and severe hypoglycemia due to abnormal secretion of insulin-like growth factor: a case report. ( 10326704 )
1999
42
Management of recurrent meningeal hemangiopericytoma. ( 9587125 )
1998
43
Radiotherapy of bone metastases of a spinal meningeal hemangiopericytoma. ( 9581183 )
1998
44
Metastatic meningeal hemangiopericytoma of thoracic spine. ( 9822848 )
1998
45
The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. ( 9351573 )
1997
46
[X-ray computed tomographic aspects of malignant meningioma and meningeal hemangiopericytoma]. ( 8696997 )
1996
47
Meningeal hemangiopericytoma metastatic to the heart. ( 8776772 )
1996
48
The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma. ( 8858518 )
1996
49
Insulin-like growth factor II expression in primary meningeal hemangiopericytoma and its metastasis to the liver accompanied by hypoglycemia. ( 8760024 )
1996
50
Soft-tissue and meningeal hemangiopericytomas: an immunohistochemical and ultrastructural study. ( 2318483 )
1990

Variations for Meninges Hemangiopericytoma

Expression for Meninges Hemangiopericytoma

Search GEO for disease gene expression data for Meninges Hemangiopericytoma.

Pathways for Meninges Hemangiopericytoma

Pathways related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.52 HEY1 IGF2 STAT6
2
Show member pathways
11.41 IGF2 NCOA2
3 11.28 NCOA2 STAT6
4 11.01 STAT6 VIM

GO Terms for Meninges Hemangiopericytoma

Biological processes related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of transcription, DNA-templated GO:0006355 9.46 HEY1 IGF2 NCOA2 STAT6
2 positive regulation of transcription by RNA polymerase II GO:0045944 9.26 HEY1 IGF2 NCOA2 STAT6
3 negative regulation of transcription by RNA polymerase II GO:0000122 8.92 HEY1 IGF2 NCOA2 STAT6

Sources for Meninges Hemangiopericytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....